Healthcare >> CEO Interviews >> February 17, 2000

Scott Rifkin – Americasdoctors.com Inc

STEVEN M. RAUSCHER is President and Chief Executive Officer of Oscient Pharmaceuticals Corporation. He has been a director since 1993 and joined the company full-time as President and Chief Executive Officer in 2000. Before joining Oscient Pharmaceuticals, Mr. Rauscher spent 18 years at Abbott Laboratories, serving in a variety of key leadership positions including Vice President for Corporate Licensing; Vice President of Business Development; Vice President of Sales U.S. Pharmaceutical Products Division; Director of Strategic Planning for Pharmaceutical Products; and General Manager, Abbott West Indies. Following his time at Abbott, Mr. Rauscher served as CEO of AmericasDoctor, a company that provides clinical research and marketing services to the pharmaceutical industry. Mr. Rauscher holds an MBA from the University of Chicago. Profile
SCOTT RIFKIN, MD, is the Founder and Chairman of the Board of Directors of AmericasDoctor.com. Dr. Rifkin founded AmericasDoctor.com in September 1998 when it became an anchor tenant on the America Online Health Channel (keyword: AmDoc). The AmericasDoctor.com Web site was launched in March 1999 and has since become one the most recognized health information destinations on the Internet. Dr. Rifkin is a native of the Baltimore area where he received a Bachelor's Degree in Biology from the University of Maryland's Baltimore County Campus. He graduated from the George Washington University School of Medicine. Currently Dr. Rifkin is the founder and Chairman of AmericasDoctor.com Inc. He is certified in Internal Medicine and has a private practice in Owings Mills, Maryland. Dr. Rifkin has been named as a 'Top Doc' by Baltimore Magazine, serves on the editorial board of Physician Practice Digest, and is a frequent speaker at regional and national events. Profile
TWST: Give us a brief overview of Americas Doctor.com Inc.

Dr. Rifkin: Our history is one in which two leading edge companies have

combined to form a unique e-research entity. You